IL17A and leukemia: Coculture with Th17 cells increased the percentage of the Ki67+ leukemia subpopulation and the survival of Ph+ B-ALL cells, and these changes were abolished by treatment with the anti-IL-17A neutralizing antibody (anti-IL-17A) (Fig. 2b, c).